STK11 and neoplasm: Notably, dNTP biosynthesis can be promoted by the inactivation of the p53 and LKB1 (also known as STK11) tumour suppressors, or by activation of MYC, RAS and AKT oncogenes (Fig. 2) (Villa et al., 2019).